Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$708,618
+$144,449 QoQ
Shares Held
2,816
+8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,864
of 4,153 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walkner Condon Financial Advisors LLC holds $5,850,924 across 8 Drug Manufacturers - General names. ABBV ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,536 | $1,842,324 | |
| 2 | JNJ |
Johnson & Johnson
|
4,063 | $1,031,880 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,816 | $708,618 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,409 | $683,373 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,354 | $559,489 | |
| 6 | NVS |
Novartis AG
|
2,701 | $423,300 | |
| 7 | AMGN |
Amgen Inc
|
1,035 | $374,794 | |
| 8 | PFE |
Pfizer Inc
|
9,433 | $227,146 |
All Filings in ABBV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $708,618 | 2,816 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $564,169 | 2,594 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $735,509 | 3,219 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $715,458 | 3,090 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $470,175 | 2,533 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $463,458 | 2,212 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $364,640 | 2,052 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $377,186 | 1,910 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $290,554 | 1,694 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $490,395 | 2,693 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $377,506 | 2,436 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $335,981 | 2,254 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $288,995 | 2,145 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $476,994 | 2,993 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $461,073 | 2,853 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $336,732 | 2,509 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $372,485 | 2,432 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $321,626 | 1,984 | Shares | Sole | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||